Activation of nicotinic receptors on GABAergic amacrine cells in the rabbit retina indirectly stimulates dopamine release

The retina possesses subpopulations of amacrine cells, which utilize different transmitters, including acetylcholine (ACh), GABA, and dopamine. We have examined interactions between these neurones by studying the effects of nicotinic agonists on GABA and dopamine release. Isolated rabbit retinas wer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Visual neuroscience 2001-01, Vol.18 (1), p.55-64
Hauptverfasser: NEAL, MICHAEL J., CUNNINGHAM, JOANNA R., MATTHEWS, KIM L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 64
container_issue 1
container_start_page 55
container_title Visual neuroscience
container_volume 18
creator NEAL, MICHAEL J.
CUNNINGHAM, JOANNA R.
MATTHEWS, KIM L.
description The retina possesses subpopulations of amacrine cells, which utilize different transmitters, including acetylcholine (ACh), GABA, and dopamine. We have examined interactions between these neurones by studying the effects of nicotinic agonists on GABA and dopamine release. Isolated rabbit retinas were incubated with [3H]dopamine and then superfused. Fractions of the superfusate (2 min) were collected and the [3H]dopamine in each sample was measured. Endogenous GABA release was examined by incubating retinas in a small chamber. At 5-min intervals, the medium was changed and the GABA measured by high-pressure liquid chromatography (HPLC). Exposure of the retina to nicotine, epibatidine, and other nicotinic agonists increased the release of both GABA and dopamine. The effects of nicotine and epibatidine were blocked by mecamylamine, confirming an action on nicotinic receptors. The action of epibatidine on dopamine release was unaffected by glutamate antagonists but was blocked by picrotoxin and gabazine. These results suggested that nicotine might increase dopamine release indirectly by stimulating the release of GABA, which in turn inhibited the release of an inhibitory transmitter acting tonically on the dopaminergic amacrines. Exposure of the retina to GABA caused a small increase in dopamine release. This hypothetical inhibitory transmitter was not GABA, an opioid, adenosine, glycine, nociceptin, a cannabinoid, or nitric oxide because appropriate antagonists did not affect the resting release of dopamine. However, metergoline, a 5HT1/5HT2 receptor antagonist, and ketanserin, a 5HT2A receptor antagonist, but not the 5HT1A antagonist WAY100635, increased the resting release of dopamine and blocked the effects of nicotine. The 5HT1A/5HT7 agonist 8-hydroxy DPAT inhibited both the nicotine and GABA-evoked release of dopamine. We conclude that nicotinic agonists directly stimulate the release of GABA, but the evoked release of dopamine is indirect, and arises from GABA inhibiting the input of an inhibitory transmitter, which we tentatively identify as serotonin.
doi_str_mv 10.1017/S0952523801181058
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70841824</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0952523801181058</cupid><sourcerecordid>1403407391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-8c2df683bf6a3d37e2bcdaa3c87ea48e8f89b255abf2664fa28b131382b734803</originalsourceid><addsrcrecordid>eNp1kUuLFDEUhYMoTjv6A9xIEHFXmldVbi97Ru0RBkTUzWzCTSo1ZqxHT5IS-9-bshsdFDcJ3POdy7kcQp5y9oozrl9_Yuta1EIC4xw4q-EeWXHVrCvQXN0nq0WuFv2EPErphjEueS0fkhPOpdLAmxXZb1wO3zGHaaRTR8fgphzKS6N3fpenmGhRtpuzjY_XZYwDuhhGT53v-0TDSPNXTyNaG3LxFC-WYRuKPfd7mnIY5h6zT7Sddjgszuh7j8k_Jg867JN_cvxPyZd3bz-fX1SXH7bvzzeXlVMgcwVOtF0D0nYNylZqL6xrEaUD7VGBhw7WVtQ12k40jepQgC1nShBWSwVMnpKXh727ON3OPmUzhLSkx9FPczKageIgVAGf_wXeTHMcSzbD1yC5EiAKxA-Qi1NK0XdmF8OAcW84M0sp5p9SiufZcfFsB9_-cRxbKMCLI4DJYd9FHF1IdzgmxK891QELKfsfv2WM30yjpa5Ns_1orq7OtvAGtLkovDxmxcHG0F77Oxf9N-1PmXuzSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198314282</pqid></control><display><type>article</type><title>Activation of nicotinic receptors on GABAergic amacrine cells in the rabbit retina indirectly stimulates dopamine release</title><source>MEDLINE</source><source>Cambridge Journals - Connect here FIRST to enable access</source><creator>NEAL, MICHAEL J. ; CUNNINGHAM, JOANNA R. ; MATTHEWS, KIM L.</creator><creatorcontrib>NEAL, MICHAEL J. ; CUNNINGHAM, JOANNA R. ; MATTHEWS, KIM L.</creatorcontrib><description>The retina possesses subpopulations of amacrine cells, which utilize different transmitters, including acetylcholine (ACh), GABA, and dopamine. We have examined interactions between these neurones by studying the effects of nicotinic agonists on GABA and dopamine release. Isolated rabbit retinas were incubated with [3H]dopamine and then superfused. Fractions of the superfusate (2 min) were collected and the [3H]dopamine in each sample was measured. Endogenous GABA release was examined by incubating retinas in a small chamber. At 5-min intervals, the medium was changed and the GABA measured by high-pressure liquid chromatography (HPLC). Exposure of the retina to nicotine, epibatidine, and other nicotinic agonists increased the release of both GABA and dopamine. The effects of nicotine and epibatidine were blocked by mecamylamine, confirming an action on nicotinic receptors. The action of epibatidine on dopamine release was unaffected by glutamate antagonists but was blocked by picrotoxin and gabazine. These results suggested that nicotine might increase dopamine release indirectly by stimulating the release of GABA, which in turn inhibited the release of an inhibitory transmitter acting tonically on the dopaminergic amacrines. Exposure of the retina to GABA caused a small increase in dopamine release. This hypothetical inhibitory transmitter was not GABA, an opioid, adenosine, glycine, nociceptin, a cannabinoid, or nitric oxide because appropriate antagonists did not affect the resting release of dopamine. However, metergoline, a 5HT1/5HT2 receptor antagonist, and ketanserin, a 5HT2A receptor antagonist, but not the 5HT1A antagonist WAY100635, increased the resting release of dopamine and blocked the effects of nicotine. The 5HT1A/5HT7 agonist 8-hydroxy DPAT inhibited both the nicotine and GABA-evoked release of dopamine. We conclude that nicotinic agonists directly stimulate the release of GABA, but the evoked release of dopamine is indirect, and arises from GABA inhibiting the input of an inhibitory transmitter, which we tentatively identify as serotonin.</description><identifier>ISSN: 0952-5238</identifier><identifier>EISSN: 1469-8714</identifier><identifier>DOI: 10.1017/S0952523801181058</identifier><identifier>PMID: 11347816</identifier><language>eng</language><publisher>New York, NY: Cambridge University Press</publisher><subject>ACh ; Animals ; Biological and medical sciences ; Central nervous system ; Central neurotransmission. Neuromudulation. Pathways and receptors ; Chromatography, High Pressure Liquid ; Dopamine - metabolism ; Dopamine - pharmacology ; Dopamine release ; Excitatory Amino Acid Antagonists - pharmacology ; Fundamental and applied biological sciences. Psychology ; GABA Antagonists - pharmacology ; GABA release ; gamma-Aminobutyric Acid - metabolism ; gamma-Aminobutyric Acid - pharmacology ; Male ; Neurons - drug effects ; Neurons - metabolism ; Nicotinic Agonists - pharmacology ; Nicotinic Antagonists - pharmacology ; Nicotinic receptors ; Rabbits ; Receptors, Nicotinic - metabolism ; Retina ; Retina - drug effects ; Retina - metabolism ; Serotonin ; Serotonin Antagonists - pharmacology ; Vertebrates: nervous system and sense organs</subject><ispartof>Visual neuroscience, 2001-01, Vol.18 (1), p.55-64</ispartof><rights>2001 Cambridge University Press</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-8c2df683bf6a3d37e2bcdaa3c87ea48e8f89b255abf2664fa28b131382b734803</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0952523801181058/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,780,784,4024,27923,27924,27925,55628</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1102258$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11347816$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NEAL, MICHAEL J.</creatorcontrib><creatorcontrib>CUNNINGHAM, JOANNA R.</creatorcontrib><creatorcontrib>MATTHEWS, KIM L.</creatorcontrib><title>Activation of nicotinic receptors on GABAergic amacrine cells in the rabbit retina indirectly stimulates dopamine release</title><title>Visual neuroscience</title><addtitle>Vis Neurosci</addtitle><description>The retina possesses subpopulations of amacrine cells, which utilize different transmitters, including acetylcholine (ACh), GABA, and dopamine. We have examined interactions between these neurones by studying the effects of nicotinic agonists on GABA and dopamine release. Isolated rabbit retinas were incubated with [3H]dopamine and then superfused. Fractions of the superfusate (2 min) were collected and the [3H]dopamine in each sample was measured. Endogenous GABA release was examined by incubating retinas in a small chamber. At 5-min intervals, the medium was changed and the GABA measured by high-pressure liquid chromatography (HPLC). Exposure of the retina to nicotine, epibatidine, and other nicotinic agonists increased the release of both GABA and dopamine. The effects of nicotine and epibatidine were blocked by mecamylamine, confirming an action on nicotinic receptors. The action of epibatidine on dopamine release was unaffected by glutamate antagonists but was blocked by picrotoxin and gabazine. These results suggested that nicotine might increase dopamine release indirectly by stimulating the release of GABA, which in turn inhibited the release of an inhibitory transmitter acting tonically on the dopaminergic amacrines. Exposure of the retina to GABA caused a small increase in dopamine release. This hypothetical inhibitory transmitter was not GABA, an opioid, adenosine, glycine, nociceptin, a cannabinoid, or nitric oxide because appropriate antagonists did not affect the resting release of dopamine. However, metergoline, a 5HT1/5HT2 receptor antagonist, and ketanserin, a 5HT2A receptor antagonist, but not the 5HT1A antagonist WAY100635, increased the resting release of dopamine and blocked the effects of nicotine. The 5HT1A/5HT7 agonist 8-hydroxy DPAT inhibited both the nicotine and GABA-evoked release of dopamine. We conclude that nicotinic agonists directly stimulate the release of GABA, but the evoked release of dopamine is indirect, and arises from GABA inhibiting the input of an inhibitory transmitter, which we tentatively identify as serotonin.</description><subject>ACh</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Central nervous system</subject><subject>Central neurotransmission. Neuromudulation. Pathways and receptors</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Dopamine - metabolism</subject><subject>Dopamine - pharmacology</subject><subject>Dopamine release</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>GABA Antagonists - pharmacology</subject><subject>GABA release</subject><subject>gamma-Aminobutyric Acid - metabolism</subject><subject>gamma-Aminobutyric Acid - pharmacology</subject><subject>Male</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Nicotinic Agonists - pharmacology</subject><subject>Nicotinic Antagonists - pharmacology</subject><subject>Nicotinic receptors</subject><subject>Rabbits</subject><subject>Receptors, Nicotinic - metabolism</subject><subject>Retina</subject><subject>Retina - drug effects</subject><subject>Retina - metabolism</subject><subject>Serotonin</subject><subject>Serotonin Antagonists - pharmacology</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0952-5238</issn><issn>1469-8714</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kUuLFDEUhYMoTjv6A9xIEHFXmldVbi97Ru0RBkTUzWzCTSo1ZqxHT5IS-9-bshsdFDcJ3POdy7kcQp5y9oozrl9_Yuta1EIC4xw4q-EeWXHVrCvQXN0nq0WuFv2EPErphjEueS0fkhPOpdLAmxXZb1wO3zGHaaRTR8fgphzKS6N3fpenmGhRtpuzjY_XZYwDuhhGT53v-0TDSPNXTyNaG3LxFC-WYRuKPfd7mnIY5h6zT7Sddjgszuh7j8k_Jg867JN_cvxPyZd3bz-fX1SXH7bvzzeXlVMgcwVOtF0D0nYNylZqL6xrEaUD7VGBhw7WVtQ12k40jepQgC1nShBWSwVMnpKXh727ON3OPmUzhLSkx9FPczKageIgVAGf_wXeTHMcSzbD1yC5EiAKxA-Qi1NK0XdmF8OAcW84M0sp5p9SiufZcfFsB9_-cRxbKMCLI4DJYd9FHF1IdzgmxK891QELKfsfv2WM30yjpa5Ns_1orq7OtvAGtLkovDxmxcHG0F77Oxf9N-1PmXuzSw</recordid><startdate>200101</startdate><enddate>200101</enddate><creator>NEAL, MICHAEL J.</creator><creator>CUNNINGHAM, JOANNA R.</creator><creator>MATTHEWS, KIM L.</creator><general>Cambridge University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>200101</creationdate><title>Activation of nicotinic receptors on GABAergic amacrine cells in the rabbit retina indirectly stimulates dopamine release</title><author>NEAL, MICHAEL J. ; CUNNINGHAM, JOANNA R. ; MATTHEWS, KIM L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-8c2df683bf6a3d37e2bcdaa3c87ea48e8f89b255abf2664fa28b131382b734803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>ACh</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Central nervous system</topic><topic>Central neurotransmission. Neuromudulation. Pathways and receptors</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Dopamine - metabolism</topic><topic>Dopamine - pharmacology</topic><topic>Dopamine release</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>GABA Antagonists - pharmacology</topic><topic>GABA release</topic><topic>gamma-Aminobutyric Acid - metabolism</topic><topic>gamma-Aminobutyric Acid - pharmacology</topic><topic>Male</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Nicotinic Agonists - pharmacology</topic><topic>Nicotinic Antagonists - pharmacology</topic><topic>Nicotinic receptors</topic><topic>Rabbits</topic><topic>Receptors, Nicotinic - metabolism</topic><topic>Retina</topic><topic>Retina - drug effects</topic><topic>Retina - metabolism</topic><topic>Serotonin</topic><topic>Serotonin Antagonists - pharmacology</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NEAL, MICHAEL J.</creatorcontrib><creatorcontrib>CUNNINGHAM, JOANNA R.</creatorcontrib><creatorcontrib>MATTHEWS, KIM L.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Visual neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NEAL, MICHAEL J.</au><au>CUNNINGHAM, JOANNA R.</au><au>MATTHEWS, KIM L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of nicotinic receptors on GABAergic amacrine cells in the rabbit retina indirectly stimulates dopamine release</atitle><jtitle>Visual neuroscience</jtitle><addtitle>Vis Neurosci</addtitle><date>2001-01</date><risdate>2001</risdate><volume>18</volume><issue>1</issue><spage>55</spage><epage>64</epage><pages>55-64</pages><issn>0952-5238</issn><eissn>1469-8714</eissn><abstract>The retina possesses subpopulations of amacrine cells, which utilize different transmitters, including acetylcholine (ACh), GABA, and dopamine. We have examined interactions between these neurones by studying the effects of nicotinic agonists on GABA and dopamine release. Isolated rabbit retinas were incubated with [3H]dopamine and then superfused. Fractions of the superfusate (2 min) were collected and the [3H]dopamine in each sample was measured. Endogenous GABA release was examined by incubating retinas in a small chamber. At 5-min intervals, the medium was changed and the GABA measured by high-pressure liquid chromatography (HPLC). Exposure of the retina to nicotine, epibatidine, and other nicotinic agonists increased the release of both GABA and dopamine. The effects of nicotine and epibatidine were blocked by mecamylamine, confirming an action on nicotinic receptors. The action of epibatidine on dopamine release was unaffected by glutamate antagonists but was blocked by picrotoxin and gabazine. These results suggested that nicotine might increase dopamine release indirectly by stimulating the release of GABA, which in turn inhibited the release of an inhibitory transmitter acting tonically on the dopaminergic amacrines. Exposure of the retina to GABA caused a small increase in dopamine release. This hypothetical inhibitory transmitter was not GABA, an opioid, adenosine, glycine, nociceptin, a cannabinoid, or nitric oxide because appropriate antagonists did not affect the resting release of dopamine. However, metergoline, a 5HT1/5HT2 receptor antagonist, and ketanserin, a 5HT2A receptor antagonist, but not the 5HT1A antagonist WAY100635, increased the resting release of dopamine and blocked the effects of nicotine. The 5HT1A/5HT7 agonist 8-hydroxy DPAT inhibited both the nicotine and GABA-evoked release of dopamine. We conclude that nicotinic agonists directly stimulate the release of GABA, but the evoked release of dopamine is indirect, and arises from GABA inhibiting the input of an inhibitory transmitter, which we tentatively identify as serotonin.</abstract><cop>New York, NY</cop><pub>Cambridge University Press</pub><pmid>11347816</pmid><doi>10.1017/S0952523801181058</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0952-5238
ispartof Visual neuroscience, 2001-01, Vol.18 (1), p.55-64
issn 0952-5238
1469-8714
language eng
recordid cdi_proquest_miscellaneous_70841824
source MEDLINE; Cambridge Journals - Connect here FIRST to enable access
subjects ACh
Animals
Biological and medical sciences
Central nervous system
Central neurotransmission. Neuromudulation. Pathways and receptors
Chromatography, High Pressure Liquid
Dopamine - metabolism
Dopamine - pharmacology
Dopamine release
Excitatory Amino Acid Antagonists - pharmacology
Fundamental and applied biological sciences. Psychology
GABA Antagonists - pharmacology
GABA release
gamma-Aminobutyric Acid - metabolism
gamma-Aminobutyric Acid - pharmacology
Male
Neurons - drug effects
Neurons - metabolism
Nicotinic Agonists - pharmacology
Nicotinic Antagonists - pharmacology
Nicotinic receptors
Rabbits
Receptors, Nicotinic - metabolism
Retina
Retina - drug effects
Retina - metabolism
Serotonin
Serotonin Antagonists - pharmacology
Vertebrates: nervous system and sense organs
title Activation of nicotinic receptors on GABAergic amacrine cells in the rabbit retina indirectly stimulates dopamine release
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A56%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20nicotinic%20receptors%20on%20GABAergic%20amacrine%20cells%20in%20the%20rabbit%20retina%20indirectly%20stimulates%20dopamine%20release&rft.jtitle=Visual%20neuroscience&rft.au=NEAL,%20MICHAEL%20J.&rft.date=2001-01&rft.volume=18&rft.issue=1&rft.spage=55&rft.epage=64&rft.pages=55-64&rft.issn=0952-5238&rft.eissn=1469-8714&rft_id=info:doi/10.1017/S0952523801181058&rft_dat=%3Cproquest_cross%3E1403407391%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=198314282&rft_id=info:pmid/11347816&rft_cupid=10_1017_S0952523801181058&rfr_iscdi=true